These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2823441)

  • 1. Medical options in the management of stages 1 and 2 (N0-N3, M0) testicular germ cell tumors.
    Oliver RT; Freedman LS; Parkinson MC; Peckham MJ
    Urol Clin North Am; 1987 Nov; 14(4):721-30. PubMed ID: 2823441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of stage I nonseminomatous testicular germ cell tumors.
    Pectasides D; Farmakis D; Pectasides M
    Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of subdiaphragmatic lymph node metastases of primary testicular seminoma (stage II)].
    Gardani G; Lattuada A; Valvo F
    Radiol Med; 1989; 77(1-2):104-14. PubMed ID: 2928559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant treatment for stage I of testicular germ cell tumours].
    Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
    Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of clinical stage I nonseminomatous germ cell testicular cancer.
    Choueiri TK; Stephenson AJ; Gilligan T; Klein EA
    Urol Clin North Am; 2007 May; 34(2):137-48; abstract viii. PubMed ID: 17484919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of germ cell tumors at the threshold of the third millennium].
    Géczi L; Biron P; Droz JP
    Orv Hetil; 2001 Aug; 142(31):1673-9. PubMed ID: 11556261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk-guided after-care of testicular tumor].
    Schölermann KH; Dettmann R; Hartmann M
    Urologe A; 1996 Jul; 35(4):326-30. PubMed ID: 8928363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment in the management of testis-confined germ cell tumours after orchidectomy.
    Sava T; Consoli F; Santo A; Cetto GL
    BJU Int; 2008 Jan; 101(2):155-9. PubMed ID: 17662077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular germ-cell neoplasms: curative approaches.
    Rowland RG
    Hematol Oncol Clin North Am; 1988 Sep; 2(3):467-84. PubMed ID: 3053595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of biological prognostic factors on therapy of non-seminomatous stage I testicular tumors--an assessment of the current status].
    Kuczyk MA; Bokemeyer C; Serth J; Machtens S; Höfner K; Jonas U
    Urologe A; 1996 Jan; 35(1):35-45. PubMed ID: 8851847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage I testicular cancer.
    Scholz M; Höltl W
    Curr Opin Urol; 2003 Nov; 13(6):473-6. PubMed ID: 14560141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
    J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage I testicular seminoma: management and controversies.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):22-8. PubMed ID: 19046898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.